Last updated on June 2020

A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease


Brief description of study

The reason for this study is to see if the study drug mirikizumab is safe and effective in participants with moderately to severely active Crohn's disease.

Clinical Study Identifier: NCT03926130

Find a site near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.